Is This a New, Data-Led Era for Cardiology?
Diagnosis of heart failure must be rapid and accurate. However, that can be a challenge for doctors without the right information and data.
With opportunity rife all over the world, I wanted to share some of the most exciting growth happening within contract manufacturing for medical devices. Here’s five companies that everyone should be getting excited about.
For this episode of CM Conversations, Ben Thompson & Jerome Richards, Directors at CM Medical, spoke with Rob Jenkins and Will Flack from F&J Agile Solutions.
It’s only now, that a handful of pioneering start-ups have emerged with Transcatheter Tricuspid Valve Repair/Replacement (TTVR) devices to offer an alternative to surgery. I spoke to some of these companies' leading experts.
The structural heart space is one of the most exciting areas in the whole of medical devices. A broad term, covering a range of cardiac conditions, the advances in technology over the last 20 years has been extremely impressive, with no sign of slowi
From talking to experts in my network, many have pointed out a rising misconception. Some individuals among of the healthcare community believe that we’ve reached the ‘best we can get’ with CRM devices.
Cardiovascular disease is the number one cause of death globally, accounting for 17.9 million mortalities each year. To battle these ugly death-toll statistics, more companies are emerging with innovative, life-saving treatments across the globe.
Artificial Intelligence is a new technology and, for the most part, one of its biggest challenges is just working out how it will be applied. Where it can be used best, most cost-effectively and easiest to gain the best results.
The ‘implant files’ have been published. Following research conducted by over 250 journalists from 59 media organisations across 36 countries, reports of ‘adverse incidents’ stemming from implanted medical devices have hit the headlines.
It’s not often that med tech makes front page news, but it has today - with Apple’s announcement yesterday that they’re including an FDA approved ECG scanner in the Series 4, their latest smartwatch.
The Cardiac Transcatheter Valve business, particularly TAVI, is an area that has been causing disruption in the cardiovascular industry for years - slowly eating away at the Surgical Valve space.